WASHINGTON, Sept 23 ― The US Food and Drug Administration will authorise a booster dose of the Pfizer Inc and BioNTech Covid-19 vaccine for those aged 65 and older and some high-risk Americans, a Bloomberg News report said yesterday. The move would pave the way for a quick rollout of the shots....